SEEBRI BREEZHALER 44 micrograms, powder for inhalation in capsules 30 capsules
Active ingredients: Glycopyrronium bromide, Glycopyrrolate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation in capsules30 capsulesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SEEBRI BREEZHALER 44 microgrammes, poudre pour inhalation en gélule
- Pharmaceutical form
- poudre pour inhalation en gélule
- Route of administration
- inhalée
- Presentation description
- 30 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Apr 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69941269CIP72675498CIP133400926754983Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMURE DE GLYCOPYRRONIUMpoudre | 63 microgrammes · une gélule | SA |
| GLYCOPYRRONIUMpoudre | 50 microgrammes · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.